Satoshi Nishiwaki

Title: Satoshi Nishiwaki: Innovator in Pharmaceutical Diagnostics

Introduction

Satoshi Nishiwaki is a notable inventor based in Tokushima-ken, Japan. He has made significant contributions to the field of pharmaceutical preparations, particularly in the diagnosis of Helicobacter pylori infections. His innovative work has implications for improving diagnostic accuracy and patient care.

Latest Patents

Nishiwaki holds a patent for a pharmaceutical preparation designed for the diagnosis of Helicobacter pylori infection. This preparation is a coated formulation that follows a urea breath test protocol. It consists of a core composition containing at least an isotope C-labeled urea, an excipient, and a lubricant in defined proportions. The core is covered with 0.1-10 weight % of a coating agent based on 100 weight % of the core composition. This innovative preparation effectively excludes the influence of urease-producing bacteria residing in organs other than the stomach, such as the mouth and throat. As a result, it enables a diagnosis of infection without the risk of false-positive results and with reasonable rapidity.

Career Highlights

Satoshi Nishiwaki is associated with Otsuka Pharmaceutical Company, Limited, where he has contributed to advancements in pharmaceutical diagnostics. His work has been instrumental in enhancing the reliability of diagnostic tests for Helicobacter pylori infections.

Collaborations

Nishiwaki has collaborated with notable colleagues, including Kyoko Tsuchiya and Akio Okamura. Their combined expertise has furthered the development of innovative solutions in the pharmaceutical field.

Conclusion

Satoshi Nishiwaki's contributions to pharmaceutical diagnostics, particularly through his patented preparation for Helicobacter pylori infection, highlight his role as an influential inventor. His work continues to impact the medical field positively, improving diagnostic accuracy and patient outcomes.